Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant RecipientsAlexandra T. Strauss, Dorry L. Segev, Allan B. Massie et al.|Liver Transplantation|2021Cited by 61
Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responsesAlexandra T. Strauss, Allan B. Massie, Brian J. Boyarsky et al.|American Journal of Transplantation|2020Cited by 52
Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patientsArunkumar Krishnan, Tinsay A. Woreta, Laura Prichett et al.|World Journal of Gastroenterology|2022Cited by 38
Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United StatesBrian J. Boyarsky, Jacqueline Garonzik‐Wang, Jessica M. Ruck et al.|Clinical Transplantation|2020Cited by 36
Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipientsAlexandra T. Strauss, William A. Werbel, Amy Chang et al.|Liver Transplantation|2022Cited by 7